Understanding the enzymatic degradation of biodegradable polymers and strategies to control their degradation rate by Azevedo, Helena S. & Reis, R. L.
 177
 
0-8493-1936-6/05/$0.00+$1.50
© 2005 by CRC Press LLC
12
 
Understanding the 
Enzymatic Degradation 
of Biodegradable Polymers 
and Strategies to Control 
Their Degradation Rate
 
Helena S. Azevedo and Rui L. Reis
 
CONTENTS
 
12.1 Introduction ........................................................................................................................178
12.2 Importance of Biodegradability in Biomedical Applications............................................178
12.3 Degradation Processes in Biodegradable Polymers ..........................................................179
12.3.1 Chemical and Enzymatic Oxidation....................................................................180
12.3.2 Nonenzymatic Hydrolysis ...................................................................................180
12.3.3 Enzyme-Catalyzed Hydrolysis ............................................................................180
12.3.3.1 Factors Affecting Enzymatic Hydrolysis...........................................181
12.3.3.2 Potential Enzymes Involved in the Degradation of Biodegradable
Polymers, Their Activities, and Half-Lives in Human Plasma.........182
12.4
 
In Vitro
 
 Studies to Assess the Degradation Kinetics of Biodegradable Polymers ...........184
12.4.1 Degradation-Monitoring Techniques ...................................................................186
12.4.1.1 Water Absorption and Weight Loss...................................................187
12.4.1.2 Molecular Weight...............................................................................187
12.4.1.3 Crystallinity........................................................................................187
12.4.1.4 Morphology and Dimensional Changes ............................................188
12.4.1.5 Surface Chemistry..............................................................................188
12.4.1.6 Mechanical Properties........................................................................189
12.4.1.7 Isolation and Identification of Degradation Products .......................189
12.4.2 Mechanisms of Degradation................................................................................190
12.4.3 Strategies for Controlling the Degradation Rate of Biodegradable
Polymers ..............................................................................................................191
12.5 Enzymatic Degradation of Starch-Based Biomaterials — A Case in Study....................192
12.5.1 Materials and Methods ........................................................................................192
12.5.2 Results and Discussion........................................................................................192
12.6 Concluding Remarks..........................................................................................................196
Acknowledgments ..........................................................................................................................197
References ......................................................................................................................................197
 
1936_book.fm  Page 177  Wednesday, October 6, 2004  11:14 AM
 178
 
Biodegradable Systems in Tissue Engineering and Regenerative Medicine
 
12.1 INTRODUCTION
 
Nature has always provided, in considerable amounts and variety, polymeric materials with inter-
esting compositions and structures and with great potential to be used in biomedical applications.
These natural polymers include polysaccharides,
 
1
 
 such as cellulose, chitin, starch, alginate, galac-
tan, hyaluronic acid, dextran, and gellan, obtained from plants, animals, and microbial sources and
polyesters,
 
2 
 
such as poly(
 
b
 
-hydroxybutyrate) and poly(
 
b
 
-hydroxybutyrate-co-
 
b
 
-hydroxyvalerate),
produced by numerous bacteria.
 
 
 
In biological systems, polysaccharides and their derivatives are
found as energy reservoirs, as components of the cell wall of plants, in bacteria, and in the
connective tissues.
 
3,4
 
Since the early 1960s, several synthetic degradable polymer systems have been used as medical
implant materials,
 
5
 
 which include various polyesters, polyurethanes, polyanhydrides, polyacrylates,
polyphosphoesters, and polydiaxanone, among others.
 
3,6
 
 Over decades of research, many new
biomaterials have been developed, but the prospect for novel biomaterials and novel applications
continues to be immense.
Applications of biodegradable polymers in medicine (please see Chapter 1 by Suzuki and Ikada
in this book) include resorbable surgical sutures, matrices for the controlled release of drugs,
scaffolds for tissue engineering, and resorbable orthopedic devices such as bone cements, pins,
screws, and plates.
 
7
 
 The development of biomaterials requires an extensive evaluation, in terms of
biocompatibility, mechanical properties, and degradation behavior, in order to determine whether
a certain material is suitable for a particular application. Understanding the factors that control the
degradation of biomaterials is, therefore, critical for the development of degradable polymeric
systems, and a greater comprehension of these mechanisms would be helpful to optimize their
current usage. The demand for biomaterials with controlled, predictable degradation kinetics
includes a wide range of biomedical applications, and this had led to extensive research on the
degradation behavior of a variety of biodegradable polymers. Great attention has been devoted to
the study of degradation mechanisms of poly(lactic acid)-based polymeric systems, and a vast
literature (research articles
 
8–15
 
 and reviews
 
6,16
 
) is now available.
This chapter intends to provide the reader with an overview on the degradation mechanisms
of biodegradable polymers with special emphasis on the main parameters affecting the enzymatic
degradation of polymeric biomaterials. For that, a range of potential enzymes involved in the
degradation of polymeric biomaterials will be considered, taking into account their normal levels
in the human body fluids and their secretion during inflammatory responses. Some guidelines will
be given for designing 
 
in vitro
 
 degradation studies, including a detailed description of the main
characterization techniques that should be used to evaluate the degradation behavior of biomaterials
under specific conditions. At the end of the chapter, a practical study about the enzymatic degra-
dation of starch-based polymers will be presented and discussed, as well as a case study that was
aimed to assess the degradation behavior of starch-based polymeric biomaterials under the influence
of certain enzyme activities. In addition, the effect of 
 
a
 
-amylase encapsulation in starch-based
matrices on their degradation profile was studied and will be presented herein with the perspective
of developing biomaterials with enzymatically controlled degradation rates.
 
12.2 IMPORTANCE OF BIODEGRADABILITY IN 
BIOMEDICAL APPLICATIONS
 
The term 
 
biodegradation
 
 is often used to denote degradation occurring in a biological environment.
In the context of biomedical applications, biodegradation may be defined as the “gradual breakdown
of a material mediated by a specific biological activity.”
 
17
 
The performance of medical devices depends largely on the stability of the material, and
biodegradation is a key issue on the list of safety standards when choosing materials for biomedical
applications.
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Biodegradable polymers are materials with the ability to function for a temporary period and
subsequently degrade, under a controlled mechanism, into products easily eliminated in the body’s
metabolic pathways. In this way, biodegradability not only eliminates the risk of complications
associated with the long-term presence of a foreign material and the need for a second surgery for
implant removal, but also allows for improved healing, as viable tissue interacts and grows into
the degrading construct.
The use of polymeric materials in drug delivery applications also requires that the polymer
degrade under physiological conditions and slowly release the encapsulated drug. The polymer
should demonstrate, therefore, a continuous mass loss profile to facilitate repeated dosing and to
ensure the successful effect of the treatments.
The degradation of biomaterials is also important in terms of biocompatibility, since the changes
that occur in the physicochemical properties of the materials during degradation may alter their
functionality and the associated biological response. In addition, the nature of the degradation
products will, in part, define the ultimate biocompatibility of the materials since it may also induce
alterations to cellular function.
Understanding the degradation mechanisms of biomaterials (degradation kinetics, evolution of
mechanical properties, identification of degradation products) is, therefore, of crucial importance
when selecting and designing materials for specific applications since the degradation process may
affect a range of events such as cell growth, tissue regeneration, drug release, host response, and
the material function.
 
12.3 DEGRADATION PROCESSES IN BIODEGRADABLE POLYMERS
 
The degradation of a biomaterial can occur at different stages of its preparation, including during
its storage. For instance, it was observed that the molecular weight of poly(
 
L
 
-lactide) decreased
from 431,000 to 202,000 Da upon storage.
 
8
 
The conditions used during the processing and fabrication of polymeric materials may also
lead to polymer degradation, consequently influencing their degradation behavior 
 
in vivo
 
. Melt-
based techniques (injection molding, extrusion, compression molding) are performed at high tem-
peratures and in the first two cases at high shear rates, which may cause some degradation of the
material. The production of samples by injection molding leads to a partial material orientation,
which is typically higher in the skin than in the core of the molding. The chain orientation across
the sample upon processing may be responsible for a faster degradation in the center than in the
skin.
 
8
 
 In addition, it is very common to use additives (plasticizers, lubricants, antioxidants, salts,
stabilizers) during the processing of polymeric materials, which will leach out after immersion and
may enhance or inhibit the degradation process.
Another aspect to be considered is the fact that biomedical materials need sterilization before
being implanted. Sterilization can be performed using heat, steam, gas (ethylene oxide, EtO), or
ionizing radiation, mainly 
 
g
 
 or 
 
b
 
. Each of these sterilization methods may have an effect on the
material degradation, but sterilization by radiation requires high doses of high-energy radiation,
resulting in some cases in polymer crosslinking and degradation. 
 
g
 
 sterilization was shown to reduce
significantly the molecular weight of poly(lactide–glycolide) polymers,
 
6
 
 but cold-cycle EtOH ster-
ilization did not cause any changes in the molecular weight of polylactides.
 
8
 
 Mechanical stress
may also affect the degradation, either as a result of loading under service or due to residual stress
arising during manufacturing, but this type of degradation is more significant on materials subjected
to mechanical stress such as sutures, scaffolds for tissue engineering, and fixation devices.
 
6 
 
Materials exposed to the body fluids may undergo changes in their physicochemical properties
as a result of chemical, physical, mechanical, and biological interactions between the material and
the surrounding environment. Although materials can be degraded by thermal and mechanical
processes, only degradation by oxidation and hydrolysis will be discussed in more detail in the
following sections of the present chapter.
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12.3.1 C
 
HEMICAL
 
 
 
AND
 
 E
 
NZYMATIC
 
 O
 
XIDATION
 
Polymeric biomaterials may be degraded by chemical and enzymatic oxidation when exposed to
the body fluids and tissues. It is well known that during inflammatory response to foreign materials,
inflammatory cells, particularly leukocytes and macrophages, are able to produce highly reactive
oxygen species such as superoxide (O
 
2
–
 
), hydrogen peroxide (H
 
2
 
O
 
2
 
), nitric oxide (NO), and
hypochlorous acid (HOCl).
 
17–19
 
 The oxidative effect of these species may cause polymer chain
scission and contribute to their degradation.
Several studies have been carried out to assess the effect of oxygen species in the degradation
of polymeric biomaterials.
 
17,19,20
 
 Lee and Chu
 
20
 
 
 
studied the role of superoxide in the degradation
of absorbable sutures and found that O
 
2
–
 
 could accelerate the degradation of aliphatic polyesters
by the cleavage of ester bonds via nucleophilic attack of O
 
2
–
 
.
The effect of oxidative enzymes, such as horseradish peroxidase, catalase, and xanthine oxidase,
on the degradation of poly(urethane)s (PUs) was also studied, but these oxidative systems were
unable to induce degradation of PUs.
 
21,22
 
A more detailed description about how oxidative enzymes, free radicals, superoxides, and
peroxides influence the degradation of biomedical polymers can be found in a review by Williams
and Zhong.
 
17
 
12.3.2 N
 
ONENZYMATIC
 
 H
 
YDROLYSIS
 
Polymer hydrolytic degradation may be defined as the scission of chemical bonds in the polymer
backbone by the attack of water to form oligomers and finally monomers. In the first step, water
contacts the water-labile bond, by either direct access to the polymer surface or by imbibition into
the polymer matrix followed by bond hydrolysis. Hydrolysis reactions may be catalyzed by acids,
bases, salts, or enzymes.
 
17
 
After implantation, the biomaterial absorbs water and swells, and degradation will progress
from the exterior of the material toward its interior.
The hydrophilic and hydrophobic nature of polymeric materials influences their degradation
rate, and the susceptibility to hydrolysis follows this order
 
17
 
: (1) hydrophilic with hydrolysable
bonds, (2) hydrophobic with hydrolysable bonds, (3) hydrophilic with no hydrolysable bonds, and
(4) hydrophobic with no hydrolysable bonds. For instances,
 
 N
 
-vinylpyrrolidinone (NVP) is capable
of absorbing relatively large amounts of water, but it is not prone to hydrolysis.
 
23
 
All biodegradable polymers contain hydrolysable bonds, such as glycosides, esters, orthoesters,
anhydrides, carbonates, amides, urethanes, ureas, etc.
 
3,6,17
 
 Polymers with strong covalent bonds in
the backbone (like C-C) and with no hydrolysable groups require longer times to degrade.
 
3,24
12.3.3 E
 
NZYME
 
-C
 
ATALYZED
 
 H
 
YDROLYSIS
 
Enzymes are biological catalysts, i.e., they accelerate the reaction rates in living organisms without
undergoing themselves any permanent change. In fact, in the absence of enzymes, most of the
reactions of cellular metabolism would not occur. Hydrolysis reactions may be catalyzed by
enzymes known as hydrolases, which include proteases, esterases, glycosidases, and phosphatases,
among others. This class of enzymes comprises cell-derived proteins that are responsible for the
catalysis of several reactions in the human body. For example, hydrolytic enzymes are present in
the plasma and interstitium, in the brush border membrane and lumen of the gastrointestinal tract,
and in the tubular epithelium of the kidneys, where they ensure the efficient hydrolysis of different
substrates to facilitate absorption of nutrients and solutes.
 
4
 
In this sense, it is expected that some of these enzymes may play an important role in the
degradation of biomaterials by catalyzing their hydrolysis. It has been shown that the degree of
biodegradation of polyurethanes, in the presence of cholesterol esterase enzyme, is about 10 times
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higher than in the presence of buffer alone.
 
21
 
 This fact may explain the higher 
 
in vivo
 
 degradation
rates of some biomaterials when compared with 
 
in vitro
 
 experiments.
While some enzymes catalyze only one reaction involving only certain substrates, others are
not very specific. This indicates that the degradation of synthetic polymers may also occur by
enzymatic hydrolysis, and some examples of this will be given in Section 12.3.3.2.
 
12.3.3.1 Factors Affecting Enzymatic Hydrolysis
 
The enzymatic hydrolysis of polymeric biomaterials is a heterogeneous process that is affected by
the mode of interaction between the enzymes and the polymeric chains and involves typically four
steps
 
25
 
: (1) diffusion of the enzyme from the bulk solution to the solid surface, (2) adsorption of
the enzyme on the substrate, resulting in the formation of the enzyme–substrate complex, (3)
catalysis of the hydrolysis reaction, and (4) diffusion of the soluble degradation products from the
solid substrate to the solution. The rate of the global reaction is controlled by the slowest step.
The adsorption and rate of hydrolysis reaction is affected by the physicochemical properties
of the substrate (molecular weight, chemical composition, crystallinity, surface area) and also by
the inherent characteristics of a specific enzyme (activity, stability, local concentration, amino acid
composition, and 3-D conformation). It is also very important to take into account the medium
conditions such as pH and temperature, since they influence both the properties of the substrate
and of the enzyme. The presence of stabilizers, activators, or inhibitory products in the medium,
resulting from material degradation or leaching out of processing additives, may affect the enzyme-
catalyzed reactions by influencing enzyme adsorption and activity.
The enzymatic hydrolysis of solid substrates is normally characterized by an enzyme saturation
point; at this enzyme concentration, no further increase in the degradation rate is observed when
more enzyme is added. This has been attributed to a decrease in the exposed polymer surface as
the enzyme molecules saturate the surface and appears to be limiting the progress of degradation
of some biomaterials. Such behavior was not observed by Tang et al.,
 
26
 
 who studied the effect of
enzyme concentration (cholesterol esterase, CE) on the degradation rate of polycarbonate poly-
urethanes (PCNUs). These authors found that the degradation of PCNUs was highly dependent
on enzyme dose, and the dose response was influenced by the surface chemistry and structure of
the polymer.
The chemical modification of polymers (crosslinking, removal, or introduction of chemical
groups in the polymer chain) also affects the enzymatic degradation rates since, depending on the
degree of chemical modification, it may compromise the ability of the enzyme to recognize the
modified substrate. This seems to be the case of lysozyme (enzyme responsible for the degradation
of peptidoglycan and also chitin materials), which exhibited low activity toward chitosans with
high degrees of deacetylation
 
27,28 
 
or crosslinked chitosan.
 
29
 
It was shown that different hard segment distributions at the surfaces of polyether-urea-urethanes
could influence the manner in which the enzyme cholesterol esterase adsorbs, binds, and expresses
its activity on the surface of the polymers.
 
30–32
 
 It was found, for instance, that as hard segment
increased, the enzyme hydrolytic activity was reduced.
 
32
 
The complex chemical nature of body fluids and inflamed tissues around the implant, the
variability in the polymer material, and the variability associated with biological systems (e.g., rate
of metabolism of the host)
 
 
 
make the overall degradation
 
 
 
of biomaterials a rather complicated
process. The first interaction of an implanted biomaterial with the host tissue is the adsorption of
proteins. The subsequent interactions are determined by the nature of the proteins adsorbed. Blood
plasma contains over 150 proteins, and any of these may adsorb to the biomaterial, depending on
the binding potential of the particular protein.
 
33
 
 Proteins may adsorb to a biomaterial surface with
low affinity and may be replaced by other proteins with higher binding affinities. The deposition
of proteins on the surface of biomaterials is followed by adherence of certain type of cells.
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The adsorption of other proteins to the polymer surface may influence the enzymatic degradation
of biomaterials. It was shown, for example, that the preadsorption of fibrinogen (Fg) onto the
modified and nonmodified surfaces of poly(ether-urethane) (PEU) polymers provided a temporary
protective effect against the hydrolytic action of cholesterol esterase (CE) enzyme.
 
34
 
 This effect
may be explained by the fact that the prior adsorption of Fg on the polymer surface might have
occupied sites for CE adsorption, consequently limiting the access of the enzyme to the susceptible
hydrolysable bonds. Another explanation may be related to the inability of the degradation products
to release from the polymer surface due to the adsorbed layer of Fg in the immediate area.
 
12.3.3.2 Potential Enzymes Involved in the Degradation of Biodegradable 
Polymers, Their Activities, and Half-Lives in Human Plasma
 
The enzymes present in serum can be divided into two categories
 
35
 
: (1) plasma-specific enzymes
and (2) non-plasma-specific enzymes. The former are enzymes whose normal function is related
to blood coagulation, complement activation, and lipoprotein metabolism. The latter are enzymes
that have no physiological function in the plasma, whose cofactors or even substrates are not
normally present in the plasma. This category includes enzymes that are secreted by tissues —
e.g., amylase, lipase, phosphatases — and also enzymes associated with cellular metabolism.
 
35
 
Their presence in the serum at low levels may be due to the turnover of cells within the tissue
causing release of the enzyme. The determination of enzyme activities in plasma has been used
for clinical diagnosis since high levels of certain enzyme activities in serum may indicate tissue
damage or malfunction. It should be noted, however, that increases in enzyme activities might also
be due to other factors such as increased cell turnover, cellular proliferation, or decreased clearance
by the kidney.
 
35
 
Many of the enzymes released into the serum are normally removed at a fairly rapid rate having
low half-lives.
 
35
 
 Table 12.1 gives some reference values for the activities of some enzymes as well
their half-lives in serum.
The initial stages of certain diseases and the presence of internal injuries give rise to elevated
levels of enzyme concentrations in body fluids (lymph, blood, and urine).
 
35
 
 Inflammation usually
occurs at the biomaterial–tissue interface and reflects surface adsorption of plasma proteins, com-
plement activation, neutrophil and macrophage infiltration, hyperplasia, and release of inflammatory
mediators, free radicals, and proteolytic enzymes.
 
33
 
 The major enzymes associated with inflamma-
tory cells are indicated in Table 12.2. The concentration and composition of enzymes around the
implant depends on the progress of the inflammatory reaction, since each cell synthesizes specific
lysosomal enzymes.
An intrinsic characteristic of natural and natural-origin polymers is their ability to be degraded
by naturally occurring enzymes, which may indicate the greater propensity of these materials to
be metabolized by the physiological mechanisms.
 
17
 
TABLE 12.1
Reference Concentration and Half-Lives of Some Enzymes in 
Human Serum
 
Enzyme Concentration Ref. Half-Life (h) Ref.
 
Lysozyme 
 
a
 
-Amylase
Lipase
Alkaline phosphatase (bone)
4–13 mg/l
46–244 U/l
30–190 U/l
11 mg/l
27
36
37
38
16
 
a
 
9.3–17.7
6.9–13.7
30–50
39
40
40
35
 
a
 
After injection into HeLa cells.
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For instance, the degradation of hyaluronic acid in mammals is carried out by the concerted
action of three enzymes
 
45,46
 
: hyaluronidase, 
 
b
 
-
 
D
 
-glucuronidase, and 
 
b
 
-
 
N
 
-acetyl-
 
D
 
-hexosaminidase.
Starch and its derivatives have been widely used in the pharmaceutical industry as controlled-
release excipients for the preparation of matrix tablets,
 
25,48
 
 since starch can be enzymatically
 
TABLE 12.2
Potential Cellular Enzymes Involved in Inflammatory Response
 
Enzyme Activity/Function in Wound Healing
 
1. Proteolytic enzymes
1.1 Cathepsins (B, G, H) 
(EC 3.4.22.1)
1.2 Elastase
(EC 3.4.21.11)
1.3 Neutrophil 
Collagenase
(EC 3.4.24.34)
1.4 Trypsin
(EC3.4.21.4)
2. Hydrolysis of 
glycosides
2.1 Lysozyme 
(EC 3.2.1.17)
2.2 
 
b
 
-
 
N
 
-acetyl-
 
D
 
- 
hexosaminidase
(EC 3.2.1.52)
2.3 
 
b
 
-
 
D
 
-glucuronidase
(EC 3.2.1.31)
3. Hydrolysis of lipids
3.1 Lipase
(EC 3.1.1.3)
3.2 Phospholipase A2
(EC 3.1.1.4)
3.3 Cholesterol esterase
(EC 3.1.1.13)
4. Others
4.1 Acid phosphatase
(EC 3.1.3.2)
4.2 Alkaline phosphatase
(EC 3.1.3.1)
Hydrolysis of proteins, acting as an aminopeptidase (cleaving peptides bonds at specific amino 
acid residues).
1.1 Cathepsin B catalyses the hydrolysis of proteins with broad specificity for peptide bonds. 
Thiol protease is believed to participate in intracellular degradation and turnover of proteins. 
1.2 Hydrolysis of proteins, including elastin, cleaving preferentially at Val-|-Xaa > Ala-|-Xaa. 
Medullasin modifies the functions of natural killer cells, monocytes, and granulocytes.
1.3 Cleavage of interstitial collagens in the triple helical domain. Can degrade fibrillar type 
I, II, and III collagens.
1.4 Cleavage of peptide bonds preferentially at Arg-|-Xaa, Lys-|-Xaa. Reduces inflammation 
by dissolving blood clots and extracellular protein precipitates.
2.1 Hydrolysis of 1,4-
 
b
 
-linkages between 
 
N
 
-acetyl-
 
D
 
-glucosamine and 
 
N
 
-acetylmuramic acid 
in peptidoglycan of the prokaryote cell walls. Lysozymes have primarily a bacteriolytic 
function; those in tissues and body fluids are associated with the monocyte-macrophage 
system and enhance the activity of immunoagents.
2.2 Hydrolysis of nonreducing end 
 
N
 
-acetyl-
 
D
 
-hexosamine residues in 
 
N
 
-acetyl-
 
b
 
-
 
D
 
-
hexosaminides. It is responsible for the degradation of GM2 gangliosides and a variety of 
other molecules containing terminal 
 
N
 
-acetyl hexosamines, in the brain and other tissues.
2.3 Hydrolysis of glucuronic acid esters. Found diffusely in macrophages and fibroblasts, and 
in granular form in eosinophilic granulocytes at the implantation site. 
3.1 Hydrolysis of triglycerides to partial glycerides and fatty acids. Present in macrophage 
cells.
3.2 Catalyzes the release of fatty acids from phospholipids. It has been implicated in normal 
phospholipid remodeling, nitric oxide-induced. Together with its lysophospholipid activity, 
it is implicated in the initiation of the inflammatory response.
3.3 Enzyme with broad specificity, acting on esters of sterols and long-chain fatty acids. Found 
in monocyte-derived macrophages (MDM). It is released from the lysosomes when MDM 
are activated during chronic inflammatory response.
4.1 Hydrolysis of phosphate esters. The acid phosphatase in normal serum is derived from 
blood platelets or lysis of erythrocytes and is indicative of macrophage activity at the implant 
site.
4.2 Hydrolysis of organic phosphate esters. Enzyme associated with plasma membrane.
Data from Price, N.C. and Stevens, L., 
 
Fundamentals of Enzymology. The Cell and Molecular Biology of Catalytic Proteins
 
,
3rd ed., Oxford University Press, Oxford, 1999, chap. 8, 10; Cassim, B., Mody, G., and Bhoola, K.D., 
 
Pharmacol. Therap.
 
,
94, 1, 2002; Duguay, D.G. et al., 
 
Polym. Degrad. Stabil.
 
, 47, 229, 1995; Labow, R.S., Erfle, D.J., and Santerre, J.P.,
 
Biomaterials
 
, 16, 51, 1995; Erfle, D.J., Santerre, J.P., and Labow, R.S., 
 
Cardiovasc. Pathol.
 
, 6, 333, 1997.
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degraded by 
 
a
 
-amylase and other amylolytic enzymes to form water-soluble oligosaccharides,
resulting in polymer erosion with the concomitant drug release.
 
25,48
 
 It was also shown that 
 
a
 
-amylase
was even able to degrade chemically modified starch.
 
48
 
 A more detailed description about the
enzymatic degradation of starch-based biomaterials will be discussed in Section 12.5.
The main enzyme involved in the degradation of chitin derivatives in the body is lysozyme.
 
27
 
Although the natural substrate of lysozyme is peptidoglycan, a negatively charged polysaccharide
present in the bacteria cell walls, it has been shown to have the ability to cleave glycosidic
linkages of chitin derivatives to some extent, but its activity strongly depends on the degree of
chemical modification.
 
27–29
 
Labow and coworkers
 
22
 
 had studied extensively and characterized the enzymatic hydrolysis of
polyether-polyurethanes (PEU), polyester-polyurethanes (PESU), and polycarbonate-polyurethanes
(PCNU) by cholesterol esterase (CE), carboxyl esterase, elastase, proteinase K, thrombin, cathepsin
B, and phospholipase A
 
2
 
 enzymes. Although enzymes like elastase have been shown to be involved
in the biodegradation of PUs, CE was the enzyme showing the highest activity toward these
polymers,
 
22
 
 and further studies were carried out with this enzyme to study the effect of several
parameters on the enzymatic behavior of PUs.
 
26,30–32,34,42–44,49–61
 
The enzymatic hydrolysis of poly(
 
L
 
-lactic acid) (PLLA) polymers has been studied using
proteinase K,
 
62–64
 
 an endopeptidase enzyme responsible for the hydrolysis of peptides amides in
keratin and other proteins. It was demonstrated that this enzyme was able to accelerate the hydrolysis
of PLLA.
 
62
 
 PLLA and poly(glycolic acid) (PGA) are polymers synthesized from materials found
naturally in the body, and therefore they are expected to be degraded by enzymes. Schakenraad et
al.65 observed a slightly increased level of lactate dehydrogenase (LDH, an enzyme involved in the
conversion of lactic acid) and its coenzyme NADH-reductase in macrophages and fibroblasts after
7 days of PLA implantation in AO/BN rats. It was suggested that the increase in LDH activity
might be related to the release of L-lactic acid monomers and oligomers as a result of PLA
degradation. This means that degradation of biomaterials may induce other enzyme activities besides
the enzyme patterns observed in the early stages of implantation, which are simply related to wound
healing reaction.
Lipase is an enzyme that is able to catalyze the hydrolysis of ester bonds in polyesters when
in the presence of an aqueous media.63 It was found that certain lipases enhanced the degradation
of polycaprolactone (PCL) when compared with incubation in buffer only.66,67 The enzymatic
hydrolysis of PCL occurs mainly at the polymer surface since it is difficult for a hydrophilic
enzyme to diffuse into a hydrophobic polymer like PCL.37 The surface erosion mechanism of PCL
demonstrated by lipase enzyme may be useful to deliver bioactive agents by an enzymatically
controlled process.
Polyphosphates are a class of biodegradable polymers with a phosphodiester backbone, which
is prone to hydrolytic enzymes such as phospholipases and phosphodiesterases.68 Renier and Khon68
studied the degradation kinetics of a biodegradable polyphosphate in fetal bovine serum (FBS) and
postulated that alkaline phosphatase present in serum may cleave the phosphodiester linkage of the
backbone of polyphosphate polymers.
12.4 IN VITRO STUDIES TO ASSESS THE DEGRADATION KINETICS 
OF BIODEGRADABLE POLYMERS
In vitro degradation tests of biodegradable polymers in simple aging media are normally conducted
to predict the performance of such polymers in the clinical situation. Taking into account the
complexity of the body fluids, it is common to find different results when the same materials are
studied both in vitro and in vivo. For instance, it has been observed that in vivo degradation rates
of a linear copolymer of lactide and ethylphosphate69 and of poly(lactide-co-glycolide)
microspheres11 were faster in vivo than in vitro. The higher in vivo degradation rates of biomaterials
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have been explained by the effects caused by cellular and enzymatic activities found in the body
and to the dynamic loads experienced by devices during the implantation period. Opposite behaviors
were found by Jiang and coworkers70 who reported that the in vivo degradation of poly(ester-
anhydrides) based on aliphatic and aromatic diacids was slower than in vitro. The lower in vivo
degradation might be related to the prevention of water penetration and diffusion of degradation
products by the formed capsule around the implanted materials in vivo. Hooper et al.71 found,
however, similar in vitro and in vivo degradation rates of tyrosine-derived polymers (poly[DTE
carbonate] and poly[DTE adipate]), which confirmed the absence of enzymatic hydrolysis in the
degradation process of these materials. The differences found between in vitro and in vivo results
are possibly related to the intrinsic properties of each biomaterial and with the in vitro systems used
to simulate the in vivo conditions. Nevertheless, in vitro results may constitute a useful approach
to predict the degradation rate of biomaterials and also a guideline for planning in vivo studies.
Most of the degradation studies reported in the literature are performed by incubating the
material in phosphate buffer saline (PBS) solution. In this way, it is expected that only degradation
by normal hydrolysis will occur. Hooper and colleagues71 found that both PBS and simulated body
fluid (SBF) solutions were appropriate incubation buffers for an accurate simulation of the in vivo
degradation of tyrosine-derived polymers. Nonbuffered solutions (water, isotonic saline solutions)
have been also used in many degradation studies, but these tests had ignored the buffer capacity
of body fluids. Furthermore, many of the degradation tests do not contemplate the renewal of the
degradation medium, and again, such testing protocols do not allow for the evacuation of degra-
dation products by fluid flow, intrinsic to in vivo conditions.9
Another important issue is the mass/volume ratio used in the degradation tests. Different
mass/volume ratios have been reported in the literature, and this may affect the degradation kinetics
of biomaterials. It is known, for instance, that articular cartilage tissue is quite avascular,9,72 which
means a low level of surrounding fluids.
The choice of the incubation media, mass/volume ratio, and duration of the in vitro degradation
studies should take into account the locale where the materials will be implanted and the time that
the materials will be in contact with the tissues and body fluids. For instance, the release of acidic
degradation by-products in anatomical regions, without access to sufficient quantities of body fluids,
might overwhelm the capacity of the body fluids to ensure local buffering and cause adverse effects
to the surrounding tissues.9 Nevertheless, the use of other degradation solutions (water, serum,
enzyme buffer, ionic and simulated body fluid solutions) may provide insight into some aspects of
the degradation process of certain biomaterials since enzymes and other reactive species are
expected to be present in the in vivo environment (please see Section 12.3.3.2).
Another focus of controversy is the use of static or agitation conditions during the degradation
tests. The level of agitation may influence the degradation kinetics of biomaterials since it facilitates
the release of degradation products from the bulk or surface of the material to the solution.
Furthermore, in the case of enzyme-mediated degradation, agitation promotes the contact between
the soluble free enzyme and the insoluble substrate (biomaterial) enhancing adsorption. It is
assumed that the body fluids move slowly in soft and hard tissues, and it is suggested that
degradation tests should be performed under static16 or slow agitation (two rotations per minute)73
to mimic the physiological conditions. On the other hand, the use of different agitation conditions
during the ex vivo growth of tissues (static flasks, mixed flasks, rotating vessels, flow-perfusion
bioreactors) has been reported. It was observed that cartilage constructs cultured in a dynamic
laminar flow field in rotating vessels led to better results (in terms of size, mechanical properties,
and higher content of collagen and glycosaminoglycan) than static and agitated flasks.74 In addition,
it is expected that biomaterials will experience some fluid flow and repetitive loading when under
in vivo conditions,74 and this is likely to influence the degradation kinetics of biodegradable
polymers. The study of the degradation behavior of biomaterials under these different incubation
conditions is, therefore, important to investigate the adequacy and efficacy of the material during
1936_book.fm  Page 185  Wednesday, October 6, 2004  11:14 AM
186 Biodegradable Systems in Tissue Engineering and Regenerative Medicine
cell culture and implantation. Furthermore, these studies may also provide additional information
about the degradation mechanisms of the materials.
Agrawal et al.74 studied the effect of fluid flow on the in vitro degradation kinetics of poly(D,L-
lactide-co-glycolide) (PLG) scaffolds. Contrary to what might be expected, it was observed that
the fluid flow decreased the degradation rate significantly. This result was attributed to the absence
of the autocatalytic effect6,10,16,63 caused by the acidic by-products formed during hydrolysis of PLG
copolymers under flow conditions, since in this situation it is likely that the degradation products
are washed away. Different results may be obtained when studying other polymeric systems, since
it is expected that the effect of fluid flow may cause additional mechanical stress and contribute to
the leaching out of processing additives and fast release of degradation products, leading to increased
degradation. The degradation rate of a particular biomaterial under these conditions may not,
however, follow any of these behaviors, and only an accurate test may give indications on the type
of degradation.
The number of samples tested should always allow for a valid statistical analysis (n > 10), and
a proper control for each test period should always be used.
The great diversity of the conditions used in the various degradation studies does not allow for
direct comparisons to be made, and the use of standardized methods for characterizing the degra-
dation properties of biomaterials would be advisable. The ISO standards 10993-975 and 10993-1376
provide guidance on general requirements for the design of tests to assess the degradation of
biomaterials and to identify and quantify the degradation products from polymers, respectively. It
is also mentioned in these standards that, due to the wide range of polymeric materials used in
biomedical applications, the degradation tests should be carried out under conditions that closely
simulate the environment in which the material is going to be used and that conditions should
reflect the intended function of the material.
12.4.1 DEGRADATION-MONITORING TECHNIQUES
After implantation, biodegradable polymers may undergo a variety of changes in their physico-
chemical properties as a result of degradation. These alterations may compromise their desired
function and evoke undesirable tissue response. It is important, therefore, to characterize and
quantify the changes that occur in the biomaterial at different stages of degradation and to evaluate
the corresponding tissue response, since the tissue reaction may change during the course of the
degradation process. Hooper et al.71 observed that the tissue response of poly(L-lactic acid) and
poly(DTE adipate) after 60 days was not significantly different but, for the same degree of degra-
dation, evident differences on the tissue response were found.
In the early stages of degradation, the event with most significance is the gradual diffusion
of water solution into the polymer matrix (leading to an increase of water uptake), while little
changes occur in the sample mass, in the molecular weight, and consequently in the polymer
tensile strength. The main changes are related to the ones occurring at the polymer surface, such
as an increase of the surface roughening and surface free energy and eventually some chemical
changes due to hydrolysis. The second stage of the degradation process is characterized by a
decrease in the polymer molecular weight, as a result of chain scission and by the diffusion of
larger-molecular-weight fragments to the solution. This leads to increased weight loss and porosity
of the matrix and loss of tensile strength. Advanced stages of degradation are characterized by
collapse of the polymer matrix and dramatic decrease in molecular weight and an increase in
weight loss. Crystallinity substantially disappears, and as a consequence, there is a marked decline
in the mechanical properties.77
The main techniques used to evaluate the degradation of biomaterials can be divided into surface
analysis (infrared spectroscopy, X-ray photoelectron spectroscopy, contact angle measurements),
which are more appropriate to monitor the changes occurring in the first stages of degradation, and
bulk analysis (determination of changes in molecular weight, weight loss, temperature transitions,
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mechanical properties) for characterizing the later stages of degradation. Therefore, the selection
of the characterization techniques should be made based on the degradation stage and also on the
unique properties of the biomaterials under investigation. Some of the most common properties
and techniques used to evaluate the course of degradation of biodegradable polymers are described
in the following section.
12.4.1.1 Water Absorption and Weight Loss
The main factors influencing the wettability of polymers are related to their degree of crystallinity,
chemical composition, and aqueous media. Marois et al.78 found different water absorption behav-
iors for polyhydroxyoctanoate (PHO) films in water and in PBS solution. It was observed that
incubation in PBS led to lower water absorption than when incubated in water, and this difference
was attributed to osmotic phenomena and to the ionic strength of the PBS. The same behavior was
obtained by Li16 with PLA50 (L-LA/D-LA, 50/50) polymers.
Water uptake measurements can give, therefore, some indication of the hydrophilicity/hydro-
phobicity nature of the materials and therefore of their tendency to be degraded by hydrolysis. The
water uptake values are normally obtained after equilibrium of the materials in solution. In some
cases, the equilibrium cannot be reached because the material is degrading at the same time. In
this case, the level of water uptake usually increases with the degradation time due to an increase
in the permeability of the materials (a porous structure is normally obtained as a result of the release
of degradation products).
During degradation, the mass of the material may undergo changes, and these changes can
be monitored by comparing the mass before and after the degradation period. The material should
be dried to a constant mass before measuring the initial weight of the sample to avoid residual
moisture in the samples. The drying temperature should not exceed the temperature at which the
materials undergo irreversible changes (e.g., melting temperature). After degradation, the sample
should be washed thoroughly with distilled or deionized water to remove traces of soluble
degradation products, enzymes, salts, or other impurities and dried under vacuum conditions until
constant weight. The extent of degradation is commonly determined by calculating the percentage
of weight loss.
12.4.1.2 Molecular Weight
The determination of the polymer molecular weight (Mw) during the degradation process is one of
the most important analyses to be made when studying the degradation mechanisms of polymeric
biomaterials. Many other properties are affected by changes to the Mw, including mechanical
properties, crystallinity, weight loss, and morphology. The evolution of Mw during degradation can
be determined by gel permeation chromatography (GPC) or by viscometry techniques. The main
useful parameters to be analyzed are the number-average (Mn) and the weight-average (Mw)
molecular weights. The ratio Mw to Mn is known as the polydispersity index, which measures the
breadth of the molecular weight distribution. 
12.4.1.3 Crystallinity
In semicrystalline polymers, an increase in polymer crystallinity has been frequently observed at
early stages of degradation,8,16,79 and this is likely related to the plasticizing effect of the absorbed
water that makes chain movements possible, allowing crystallization to proceed toward thermody-
namic equilibrium.78 On the other hand, initial hydrolysis takes place at the amorphous regions,
since these regions are more accessible to water molecules and enzymes, leading to an initial
increase in the crystallinity of the polymer.15,16 The generation of crystallized monomers and
oligomers was also indicated as a source for increased crystallinity after degradation.8 As chain
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scission occurs in the crystalline regions, during later stages of degradation, a decrease in the overall
crystallinity of the polymer can be expected.77
The changes in the crystallinity of biodegradable polymers after degradation can be followed,
among other techniques, by differential scanning calorimetry (DSC) or by wide-angle x-ray dif-
fraction (WAXD). 
The analysis of crystallinity conducted by DSC is made based on changes in the glass transition
temperature (Tg), crystallization temperature (Tc), and melting temperature (Tm) and on the heat of
fusion (DH) values.
The shift, disappearance, or appearance of new and broader peaks in WAXD patterns is an
indicator of a change in the crystallinity. 
The percentage of crystallinity may be derived from DSC and WAXD data using empirical
correlations.
12.4.1.4 Morphology and Dimensional Changes
Changes in the surface morphology of biomaterials after degradation, like roughness and the
appearance of cracks or micro/macropores, may be examined by microscopy methods such as light
microscopy, scanning electron microscopy (SEM), and atomic force microscopy (AFM). In addi-
tion, AFM gives information about the sample topography at low magnifications and allows for
roughness calculations.59
The measurement of sample dimensions during the degradation process may be an important
parameter to be analyzed since, in some cases, degradation can cause dramatic morphologic changes
that may compromise the macroscopic properties of the final implant (e.g., bone cements or other
filler/fixation devices). This analysis can also provide information about the mode and direction of
the degradation font.80 Changes within the material may be analyzed by observing the sample cross
section obtained by freeze-fracturing in liquid nitrogen.
12.4.1.5 Surface Chemistry
The surface chemistry of biodegradable polymers, before and after degradation, can be analyzed
by several techniques that include Fourier transform infrared (FTIR) spectroscopy, X-ray photo-
electron spectroscopy (XPS), and contact angle measurements. The main difference between these
techniques is related to the amount of information provided and the depth of sample analyzed. XPS
analysis can give information about the elemental and chemical group composition at the material
surface (first 10 nm of surface), and the depth of penetration can be varied by the takeoff angle,
allowing the construction of depth profiles over the outermost polymeric surface.51,58 FTIR with
attenuated total reflectance (ATR) can provide information for chemical groups within the top 5
mm of the surface.3,30 In addition, reflection mode (FTIR-ATR) allows for the analysis of samples
in the wet state, which is more relevant from the biological point of view.30,31 The ability to
characterize the chemical state of wet surfaces is rather useful to analyze the mechanism by which
water could penetrate and disturb the structure of the materials. It is also known that polymer
surfaces gradually change toward a more hydrophilic structure in polar aqueous environments.81
For example, it was observed by Tang and colleagues31 that, after exposure to water, some poly-
carbonate-polyurethanes showed an increase in hydrogen-bonded carbonate carbonyls.
Contact angle measurements may give an indication on changes in the hydrophilicity of the
material surface. Higher contact angle values (which can be obtained in static sessile drop or
dynamic conditions using both the advancing and the receding contact angle) indicate generation
of a more hydrophobic surface.
The choice of technique depends, therefore, on the amount of information provided by each
technique, its availability, and its associated cost.
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Surface chemistry characterizing techniques may give indications about the type of degradation
mechanism.7,70,78,82 Marois et al.78 have used FTIR to analyze chemical changes in the structure of
polyhydroxyoctanoate (PHO) films after degradation in aqueous media, and this technique indi-
cated that the possible degradation mechanism of this material began internally, moving outwardly
to the surface.
12.4.1.6 Mechanical Properties
Certain biomedical applications, such as hard tissue replacement, require biodegradable materials
with mechanical properties typically on the same order of magnitude as those of the tissue that
it replaces. In addition, the material should degrade while maintaining a specified minimum
mechanical strength to support the formation of new tissue. Thus, in these cases, it is critical to
evaluate the mechanical performance of biomaterials during the course of their degradation.
Currently, the techniques described in the American Society for Testing and Materials (ASTM)
standards have been the most commonly used for testing tensile, bending, and compressive
properties of polymeric biomaterials.83
12.4.1.7 Isolation and Identification of Degradation Products
The development of materials for biomedical applications always requires extensive biological
testing to demonstrate the safety of both the material and its degradation components.84 A potential
disadvantage of using biodegradable polymers in biomedical applications is the eventual toxicity
of the degradation products. If the biomaterial degrades, either spontaneously or due to biological
activity, components can leach into surrounding tissues and may enter the circulation and be easily
metabolized via normal pathways, causing toxic effects systemically and in distant sites.33 It is
necessary, therefore, to identify the major species produced at different stages of degradation and
the kinetics of their formation. In addition, the release and accumulation of degradation products
may interfere with the course of degradation and with the equilibrium of degradation reactions.
The release and accumulation of some degradation products may accelerate the degradation rate
of some biomaterials. For example, the release of carboxyl end groups formed by chain cleavage
of lactide and glycolide aliphatic polyesters during hydrolysis may produce a decrease in the local
pH and further catalyze the hydrolysis of other ester bonds, a phenomenon called autocataly-
sis.6,10,16,63,80,83 On the contrary, Yaszemski et al.85 observed that the mechanical properties of a
poly(propylene fumarate) (PPF)-based composite material increased with degradation time, which
was explained by a crosslinking effect promoted by complexation between carboxylic groups,
formed from PPF degradation and accumulated in the incubation solution, with divalent calcium
ions released from b-tricalcium phosphate (b-TCP). Another possibility is the potential inhibitory
effect of degradation products on enzyme-catalyzed reactions. For example, it is known that the
hydrolysis by-products of starch (maltose and maltotriose) strongly inhibit the activity of a-
amylase.25 The release of processing additives or other degradation products may also have a
denaturation effect on enzyme activity. Taking into account the occurrence of such effects, the
renewal of degradation liquors may have, therefore, a significant impact on the degradation kinetics
of certain biomaterials.
The content of degradation solutions depends mainly on the material tested, the degradation
stage, and the incubation solution used in the degradation studies. It might contain degradation
products, enzyme, proteins, enzyme impurities, salts, and debris. The degradation solutions can be
subjected to appropriate chemical and physical analysis such as high-performance liquid chroma-
tography (HPLC), UV-visible spectrophotometry, nuclear magnetic resonance (NMR), mass spec-
troscopy (MS), or other analytical methods to identify and, if possible, quantify the main degradation
products. It may be necessary, before these analyses, to perform separation techniques for the
removal of salts, processing additives, monomers, oligomers, residual solvent released into the
1936_book.fm  Page 189  Wednesday, October 6, 2004  11:14 AM
190 Biodegradable Systems in Tissue Engineering and Regenerative Medicine
degradation solutions, or proteins and enzymes, since the presence of these components may
interfere with the identification and quantification of degradation products. Ultrafiltration mem-
branes can be used to separate high-molecular-weight components, such as proteins, from water-
soluble low-molecular-weight degradation products in the incubation media.
Analysis and quantification of the degradation products released into the incubation medium
also provide information about the modes of action of enzymes on the polymer and what linkages
are more susceptible to hydrolysis. The enzymatic degradation of polyurethanes has been assessed
by means of following the radioactive release of 14C-labeled degradation products.26,30–32,34,42–44,49–61
The determination of soluble reducing sugars may be used to assess the enzymatic hydrolysis of
polysaccharides.48,86
HPLC and MS techniques have been successfully used on the isolation and identification of
the degradation products of biodegradation of polyurethanes by cholesterol esterase.50,56,57
Chaubal and coworkers69 followed the generation of water-soluble degradation products during
the in vitro degradation of a linear copolymer of lactide and ethylphosphate by NMR.
12.4.2 MECHANISMS OF DEGRADATION
In general, the first degradation event after contact with water molecules is the hydrolytic scission
of the polymer chains leading to a decrease in the molecular weight. At this initial stage, the first
degradation products are not small enough to become soluble, and no significant change in the
material weight is detected. With increasing time, the molecular weight of degradation products is
reduced by further hydrolysis, which allows them to diffuse from the bulk material to the surface
and then to the solution, causing significant weight loss.
Polymers can be degraded by bulk degradation6,8,9,62 or surface erosion mechanisms.6,79,80,82,87
Bulk degradation is characterized by hydrolysis of chemical bonds in the polymer chain at the
center of the material, which typically results in an empty shell but maintains their size for a
considerable portion of time.16 This degradation behavior has been observed for polylactides
polymeric systems, whose degradation mechanisms are well described in the literature.6,8,15,16
Degradation by surface erosion mechanism is characterized by loss of the material from the
surface only, resulting in very predictable mass loss profiles. The materials get smaller but keep
their original geometric shape. This feature may be beneficial for delivering molecules at constant
rate and maintaining the mechanical and structural integrity of the material with degradation.
Poly(anhydrides) and poly(orthoester)s are examples of surface-eroding polymers.6,79,80,87
Enzyme-catalyzed degradation of polymeric biomaterials may follow a surface erosion mech-
anism, especially for highly crystalline and hydrophobic homopolymers. Due to their relatively
large size, the enzyme molecules cannot penetrate the tightly packed structure of certain polymers,
so that the enzymatic catalysis occurs at the polymer–enzyme interface. As the degrading surface
becomes roughened or fragmented, enzymatic action may be enhanced as a result of increased
surface area. Enzymatic degradation mechanisms of polymeric materials depend, however, on many
other factors such as chemical composition, degree of homogeneity, and processing technique.
Several different types of models have been applied to describe the degradation kinetics of
biodegradable polymers,2,6,10,42,68,88 assuming first- or second-order kinetics. Recently, computer
modeling has also been used, but some of these models did not consider diffusion theory to describe
transport phenomena.6 The mathematical model proposed by Duguay and coworkers42 describes,
in a very complete and comprehensive way, the in vitro enzymatic degradation of biomedical
polyurethanes by a single enzyme.
Despite the progress made on mathematical models to predict the degradation of biodegradable
polymers, much more data and sophisticated models are needed to apply these approaches to other
polymeric systems.
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12.4.3 STRATEGIES FOR CONTROLLING THE DEGRADATION RATE OF 
BIODEGRADABLE POLYMERS
Depending on the application (long-term implants or temporary matrices for tissue engineering and
drug delivery), three main strategies have been observed to alter the degradation rate of biodegrad-
able polymers. Some strategies intend to increase the degradation rate of biomaterials, and this is
normally obtained by blending or copolymerization techniques or by adjusting the polymer phys-
icochemical properties. The reduction of the degradation is mainly achieved by selecting the
polymer chemical composition (high degree of crystallinity, hydrophobicity, elevated molecular
weight, nonhydrolysable bonds) and by using surface modification methods. The third approach
may be obtained by selecting the right combination of the other two strategies and may take
advantage of using smart systems, which means that polymers will degrade only in response to a
certain stimulus.
The degradation of some biomaterials involves nonenzymatic hydrolysis, which is largely
nonregulated.89 In such situations, only the calendar may determine the rate of resorption of the
material, and in these cases, the degradation of biomaterials is controlled by manipulating their
physicochemical properties. Blending and copolymerization have been used to change the degra-
dation rate of polymeric materials, since, in general, blends and copolymers degrade faster than
homopolymers from the same family.
Other approaches90,91 have been used, such as including enzymatic recognition sites in polymer
backbones (e.g., amino acids) to enzymatically modulate the material degradation or making the
material sensitive to the feedback provided by the cells involved in the healing response,92 as cells
enzymatically degrade the extracellular matrix around them.
It has been observed that the inclusion of some substances into polymeric matrices, either as
excipients or drugs for controlled delivery, may change the degradation rate of some biomaterials.
The inclusion of sodium,9 calcium,9 or zinc carbonate11 into poly(lactide-co-glycolide) (PLG)
polymers was shown to retard the degradation of PLG due to the neutralization of carboxylic
acid groups formed during PLG hydrolysis by the basic salts, consequently avoiding the auto-
catalytic effect of the acidic degradation products. Birnbaum and Brannon-Peppas12 found that
the inclusion of increasing amounts of epirubicin HCl in poly(lactic-co-glycolic acid) (PLGA)
nanospheres hastened their degradation. This may be caused by an increase in water uptake due
to the free space for water to diffuse into the interior of the nanoparticles after drug dissolution
and release.
For instance, the combination of a series of surface-modifying macromolecules, containing
fluorinated end-groups, into a base polyurethane reduced the material’s susceptibility to enzymatic
hydrolysis.51,52
Kamimura et al.93 developed a self-regulated degradation system based on dextran (Dex) with
a model oxidant dihydronicotinamide (NAH) to achieve nonlinear enzymatic degradation and
consequently an oscillative drug release system. The smart system had used the combined activities
of three enzymes (dextranase, isomaltase, and glucose oxidase) to generate oxidant degradation
products (H2O2) able to oxidize NAH-Dex (NA+-Dex), which was then complexed with carboxym-
ethyl dextran (anionic polysaccharide) to form polyion complexation, consequently eliminating
further enzymatic degradation of NAH-Dex.
Materials to be used in some applications, such as hard-tissue replacement, must combine
adequate mechanical properties with controlled biodegradability. It may be difficult to achieve the
desired combination of degradation and physical properties for a single material. In this context,
it may be useful to incorporate specific enzymes into the materials by different immobilization
methods to control their degradation rate (this approach will be presented and discussed in the
next section).
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12.5 ENZYMATIC DEGRADATION OF STARCH-BASED 
BIOMATERIALS — A CASE IN STUDY
Starch-based polymers have been studied and proposed as potential materials to be used in several
biomedical applications.94–103 They have shown great versatility, are easily processed, and have
been proposed for applications such as drug delivery carrier systems,95–97 hydrogels and partially
degradable bone cements,97,98 materials for bone replacement/fixation or fillers for bone defects,98
and porous structures to be used as scaffolds in tissue engineering of bone and cartilage.99 The
degradation behavior of starch-based biomaterials in different shapes and compositions (porous
structures,96,99 hydrogels,95,97 bone cements,98 chemically modified samples,100,101 compact sam-
ples,102 composites103) has been assessed in different degradation media (namely isotonic saline
solution,96–101,103 with or without bovine serum102). The degradation rate of these materials was
shown to be dependent on certain parameters such as porosity, hydrophilicity, chemical composition,
and degree of chemical modification.96–101 The susceptibility of these starch polymeric blends to
enzymatic degradation was reported recently.86
In this section, some experimental work, regarding the susceptibility of starch-based polymers
to enzymatic degradation, will be presented and discussed. The main aim of these studies was not
to simulate the degradation of the material in vivo, but to investigate whether starch polymeric
blends could be degraded by certain enzymes with the aim of developing strategies to control their
degradation rate by enzymatic means. Furthermore, these studies may also provide insight into the
mechanistic aspects of the enzymatic degradation of these materials.
12.5.1 MATERIALS AND METHODS
The material used in this work was a polymeric blend of corn starch with poly(e-caprolactone)
(SPCL, 30/70 wt%). The blend was processed by conventional injection molding to produce
compact discs (Ø = 1 cm). The samples were incubated in phosphate buffer saline (PBS) solution
(0.01 M, pH 7.4) containing enzyme at concentration of 0.6 mg/ml (lipase from Thermomyces
lanuginosus, Novozymes A/S, Bagsvaerd, Denmark; a-amylase from Bacillus amyloliquefaciens,
Genencor International, Rochester, NY, U.S.) at 37ºC with constant shaking at 60 rpm for 6 weeks.
A control was also performed by incubating the samples in buffer alone. After degradation, the
samples were washed with distilled water and allowed to dry inside a desiccator until constant
weight was reached. The surface morphology of the samples after enzymatic degradation was
examined using scanning electron microscopy (SEM). The changes in the chemical composition
on the surface of starch-based polymers, before and after enzymatic degradation, were analyzed
by Fourier transform infrared (FTIR) spectroscopy with attenuated total reflectance (ATR) device.
With the aim of tailoring the degradation rate of starch-based biomaterials, another set of
experiments was performed by encapsulating a thermostable a-amylase in the SPCL matrices using
a melt-processing method. The encapsulant enzyme was a thermostable a-amylase (Genencor
International, Rochester, NY, U.S.) derived from a genetically modified strain of Bacillus licheni-
formis. The lyophilized enzyme was mixed with the polymer in powder form at different weight
percentages (0.5 and 5%) and processed by compression molding (P = 4 kg/cm2, T = 90ºC, 20
min) to prepare capsules (discs of ª 0.25 g). A control, without encapsulated enzyme, was also
performed. The samples were then immersed in acetate buffer solution (0.1 M, pH 5.5) and incubated
at 37ºC for different periods of time. Matrix degradation was assessed by determination of weight
loss, and the morphology of the sample surface was examined by SEM.
12.5.2 RESULTS AND DISCUSSION
Starch is a glucose homopolymer composed of amylose and amylopectin. The former is an essen-
tially linear structure where the glucose units are joined by a(1Æ4) glycosidic links, while amy-
lopectin consists of linear a(1Æ4) linked glucose chains, but is a branched molecule with a(1Æ6)
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branch points every 24 to 30 glucose residues on average. The main enzymes involved in starch
hydrolysis are a-amylases, b-amylases, glucoamylases, a-glucosidases, and other debranching
enzymes (pullulanase and isoamylase).104 a-Amylase is an endo-specific enzyme that catalyzes the
hydrolysis of a-1,4-glycosidic linkages of starch to maltose and dextrins, reducing the molecular
size of starch (Figure 12.1).48 In humans, the enzyme occurs in a variety of tissues, but the highest
concentrations are in the pancreas and in salivary glands.35 Low amylase activities are normally
detected in the serum (Table 12.1) of healthy subjects, but the concentration of a-amylase in serum
increases in individuals with acute pancreatitis or suffering from other disorders (alcoholism,
gastrointestinal disease, etc.).105
PCL is a biodegradable aliphatic polyester with important applications in the biomedical area
whose chemical structure is represented in Figure 12.1. The natural function of lipases is the
hydrolysis of triglycerides to partial glycerides and fatty acids. Serum lipase is mainly derived from
the pancreatic acinar cells, but other sources of lipase in the human body are the digestive tract,
adipose tissue, lung, milk, and leukocytes.40
Figure 12.2 shows the IR spectra of SPCL before and after degradation in different incubation
solutions. The SPCL spectrum exhibits the characteristic peaks of PCL and starch. The relevant
bands of starch are the ones related to OH group (3450 cm–1) and the band at 1150–1040 cm–1
corresponding to –C–O–C– of glycosidic bonds.106 The characteristic peaks of PCL are located at
1740 cm–1, corresponding to the C=O stretch ester carbonyl group. The peaks at 1600–1580 cm–1
and 1200–1000 cm–1 are related to asymmetric stretch of –COO– and the stretch of –C–O bond at
the main polymer chain.107
It is possible to observe that, after incubation in PBS solution, no significant changes occurred
in the chemical composition of the surface of SPCL material. The effect of a-amylase can be
observed by a decrease in the intensity of the peak at 1150–1040 cm–1, indicating the action of a-
amylase in cleaving the glycosidic linkages of starch. It is possible to visualize also a decrease of
intensity on the peak of OH group. After incubation with lipase, the main effect observed is a
significant decrease on the ester band and also on the characteristic bands of the bonds occurring
at the polymer chain (1600–1580 and 1200–1000 cm–1). The combination of the two enzymes
contributes to significant differences both on the bands of starch and PCL, indicating degradation
of both components of the polymeric blend.
The incubation of SPCL in different solutions also causes distinct surface morphologies, which
can be seen in the SEM micrographs (Figure 12.3). The incubation in buffer only (control sample)
does not cause visible changes in the sample morphology. The sample incubated with a-amylase
FIGURE 12.1 Schematic representation of the starch degradation by a-amylase and PCL by lipase.
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shows some small pores at the surface, which are probably related to the degradation of starch.
Although not visible at higher magnification, samples incubated with lipase exhibited the presence
of large fissures on the surface. At high magnification (2000 ¥), it is possible to detect changes in
the surface topography. Combining both enzymes, it is possible to observe a surface with different
topography and with small pores indicating the distinct effects of each enzyme.
Enzyme encapsulation/immobilization can be used to tailor the material degradation and, at
the same time, provide controlled-release systems of active organic and inorganic substances at a
FIGURE 12.2 IR spectra of SPCL material before and after enzymatic degradation with a-amylase and lipase.
FIGURE 12.3 SEM micrographs of SPCL surface before and after degradation in different incubation solu-
tions for 6 weeks. Magnification ¥2000. A) Untreated sample; B) PBS; C) a-amylase; D) lipase; E) a-amylase
and lipase.
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desired site and time and at a specific rate. Figure 12.4 presents the degradation behavior of SPCL
capsules in the different conditions studied. The control sample exhibits a significant weight loss
(about 13%) during the first week, but the sample mass tends to remain almost constant in the
following weeks. The original fast weight loss is related to the leaching of plasticizers and to the
release of some oligomers due to some thermal degradation of the material that occurs during
processing.86,102,103 When a-amylase was encapsulated, it is possible to observe an increase in the
weight loss as a result of the enzyme activity. With 5% of the enzyme encapsulated, almost all
starch was hydrolyzed in the first week. These results indicate that the enzyme did not lose its
activity during the preparation of the capsules, revealing a nondenaturing effect of the encapsulation
technique on the enzyme activity.
The degradation effect of the encapsulated enzyme on the surface of the material can be
observed in the SEM micrographs (Figure 12.5), where a highly porous structure is visible. This
demonstrates that the enzyme was able to degrade the starch inside the matrix and diffuse from
the bulk to the surface to carry out further starch hydrolysis. Furthermore, the encapsulation method
seems to be adequate for controlling the degradability of starch-based biomaterials, since the enzyme
possesses some degree of mobility, which is important for the degradation of insoluble substrates.
This method can, for instance, be used to incorporate a proper amount of a-amylase in starch-
based bone screws, fixation plates, or scaffolds in order to tailor their degradation profile.
Other enzyme immobilization techniques may be used to achieve biomaterials with enzymat-
ically controlled degradation (please see Chapter 17 by Costa et al. in this book). An interesting
approach is the incorporation of a-amylase during the formation of calcium phosphate (Ca-P)
coatings on starch polymeric blends with the aim of tailoring their degradation rate (please see
Chapter 14 by Leonor et al. in this book). It was shown that, using a biomimetic (“nature-inspired”)
methodology to produce Ca-P coatings on the surface of biodegradable polymers, it is possible to
incorporate enzymes without having loss of enzyme activity and at the same time tailor the
properties of the coatings (composition, morphology, crystallinity, stability, etc.).
FIGURE 12.4 Degradation profile (pH 5.5, 37ºC) of SPCL discs, measured as weight loss, containing different
percentages of encapsulated a-amylase.
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12.6 CONCLUDING REMARKS
Most of the strategies developed to achieve biomaterials with controlled degradation rates have
been based on molecular design principles such as the introduction of hydrolysable bonds into
polymer backbones, copolymerization and blending techniques, crosslinking, and surface modifi-
cation methods, depending on the type of application. The development of polymeric systems with
a degradation rate controlled by a certain stimulus may constitute, however, a very promising
approach with an increasing number of applications in the near future.
For instance, our research group proposed a new strategy to control the degradation rate of
polymeric biomaterials by incorporating polymer-degrading enzymes on the biomaterials using
different immobilization methods. The inclusion of highly sensitive molecules, such as enzymes,
into polymeric biomaterials depends very much on the conditions used during the processing of
each material, which are normally not “friendly” (high temperatures and shear rates, organic and
acid solvents). This limitation may be overcome by the progress made in protein and genetic
engineering fields, where enzyme activities (thermal and pH stabilities, substrate specificity) can
be redesigned and tailored to have specific properties. This opens new possibilities of incorporating
different biocatalysts during the processing of biomaterials that will then control their degradation
profile, allowing for novel and challenging biomedical applications.
FIGURE 12.5 SEM micrographs of the surface of SPCL discs at different stages (0, 1, and 12 weeks) of
degradation (pH 5.5, 37ºC). Magnification ¥500. (A) Control sample; (B) sample with a-amylase encapsulated
(0.5%); (C) sample with a-amylase encapsulated (5%).
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